CME Group Inc. (NASDAQ:CME) insider Bryan T. Durkin sold 14,990 shares of the business’s stock in a transaction dated Wednesday, September 28th. The stock was sold at an average price of $105.10, for a total value of $1,575,449.00. Following the completion of the sale, the insider now owns 66,936 shares in the company, valued at $7,034,973.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
CME Group Inc. (NASDAQ:CME) opened at 104.52 on Friday. The company has a 50-day moving average price of $106.83 and a 200 day moving average price of $99.14. The company has a market cap of $35.42 billion, a PE ratio of 26.39 and a beta of 0.85. CME Group Inc. has a 52 week low of $81.87 and a 52 week high of $110.35.
CME Group (NASDAQ:CME) last issued its earnings results on Thursday, July 28th. The company reported $1.14 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.11 by $0.03. CME Group had a net margin of 38.22% and a return on equity of 6.83%. The company earned $906 million during the quarter, compared to analysts’ expectations of $897.84 million. During the same period last year, the company posted $0.95 earnings per share. The firm’s quarterly revenue was up 10.5% compared to the same quarter last year. On average, equities research analysts forecast that CME Group Inc. will post $4.44 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Monday, September 26th. Shareholders of record on Friday, September 9th were issued a $0.60 dividend. The ex-dividend date was Wednesday, September 7th. This represents a $2.40 dividend on an annualized basis and a yield of 2.30%. CME Group’s dividend payout ratio (DPR) is presently 60.61%.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Glenmede Trust Co. NA boosted its position in shares of CME Group by 2.2% in the first quarter. Glenmede Trust Co. NA now owns 32,517 shares of the company’s stock worth $3,122,000 after buying an additional 710 shares during the period. Virginia Retirement System bought a new position in shares of CME Group during the first quarter worth about $500,000. CIBC World Markets Inc. bought a new position in shares of CME Group during the first quarter worth about $860,000. Ngam Advisors L.P. boosted its position in shares of CME Group by 8.9% in the first quarter. Ngam Advisors L.P. now owns 37,903 shares of the company’s stock worth $3,641,000 after buying an additional 3,094 shares during the period. Finally, TIAA CREF Investment Management LLC boosted its position in shares of CME Group by 21.8% in the first quarter. TIAA CREF Investment Management LLC now owns 989,117 shares of the company’s stock worth $95,005,000 after buying an additional 176,790 shares during the period. 80.29% of the stock is owned by institutional investors.
CME has been the topic of a number of research analyst reports. Jefferies Group boosted their target price on CME Group from $112.00 to $118.00 and gave the stock a “buy” rating in a research report on Wednesday, August 31st. JPMorgan Chase & Co. set a $116.00 price objective on CME Group and gave the company a “buy” rating in a research report on Monday, September 12th. Zacks Investment Research upgraded CME Group from a “sell” rating to a “hold” rating in a research report on Thursday, June 30th. Deutsche Bank AG upped their price objective on CME Group from $110.00 to $111.00 and gave the company a “buy” rating in a research report on Friday, July 29th. Finally, Barclays PLC decreased their price objective on CME Group from $100.00 to $99.00 and set an “equal weight” rating on the stock in a research report on Friday, July 29th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the company. CME Group has an average rating of “Hold” and an average target price of $102.89.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.